CHRS vs DVN · rev $26.6M vs P/E 7.4, rev $7.42B
Coherus BioSciences Inc (CHRS) versus Devon Energy Corporation (DVN) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
CHRS currently screens at market cap $223.7M. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Not investment advice. Open the CHRS and DVN stock pages for the full models.
Not investment advice.